[VYNE] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -11.60%
YoY- 55.56%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 135 99 6 167 126 178 2,292 -84.93%
PBT -10,038 -5,612 -7,748 -9,255 -8,235 -8,694 -12,018 -11.33%
Tax 20 10 13 204 241 -13,364 -448 -
NP -10,058 -5,622 -7,761 -9,459 -8,476 4,670 -11,570 -8.93%
Tax Rate - - - - - - - -
Total Cost 10,193 5,721 7,767 9,626 8,602 -4,492 13,862 -18.57%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -7,450.37 -5,678.79 -129,350.00 -5,664.07 -6,726.98 2,623.60 -504.80 504.66%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -3.08 -1.72 -2.60 -2.94 -2.63 1.52 -3.89 -14.45%
EPS Diluted -3.08 -1.72 -2.60 -2.94 -2.63 1.52 -3.89 -14.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.